Azar Predicts General Population Can Start Getting Vaccine By End Of Feb, Early March

Health and Human Services Secretary Alex Azar testifies before the House Select Subcommittee on the Coronavirus Crisis on October 2, 2020. (Photo by Micahel A. McCoy - Pool/Getty Images)
Start your day with TPM.
Sign up for the Morning Memo newsletter

Health and Human Services Secretary Alex Azar said on Monday morning that he anticipates that healthy Americans will be able to begin receiving the COVID-19 vaccine by the end of February to early March.

“I think we could be seeing that by late February going into March,” Azar said when asked on the “Today Show” when everyone, not just those in high risk groups such as health care workers or the elderly, can walk into their local pharmacy and get the vaccine.

With Pfizer’s vaccine already beginning its rollout, the HHS noted that there would be “significant additional supplies” if Johnson and Johnson or AstraZeneca get their vaccines approved in January.

“Late February in the March time period, I think you’ll start seeing more like a flu vaccination campaign, people going into their Kroger, their CVS, their Walgreens,” he said.

Health care workers, nursing home residents, and other vulnerable populations will start getting vaccinated over the next several days.

However, the Trump administration and Congress have provided little funding to state and local governments to help deploy the vaccine. Several health officials have told TPM that the lack of funds threatens to seriously delay the distribution process, throwing Azar’s predicted timeline into question.

Latest News
95
Show Comments

Notable Replies

  1. Liar.

  2. Avatar for darcy darcy says:

    Who the fuck asked this guy?

  3. Just like “anybody who wants a test gets a test”

    But speaking more to the substance, do we actually have any efficacy numbers for the Johnson and Johnson vaccine? That’s supposed to be a single dose vaccine so it should be extremely helpful.

    Also, the Astrazeneca/Oxford vaccine, has a fairly low efficacy (70%?) and there were a lot of basic mistakes made in their trials. Will they even be approved without a new trial? And if I go in, will I be able to choose which vaccine I get?

  4. Avatar for nycabj nycabj says:

    Good thing they didn’t reject any offers from manufacturers for additional does of the vaccine. Oh, wait.
    The admin seems to “think” that every dose of vaccine manufactured will go straight to US consumers, and that there will be plenty to go around. It probably would have been preferable if they had actually created a plan instead of a wish list.
    s/

Continue the discussion at forums.talkingpointsmemo.com

89 more replies

Participants

Avatar for fess Avatar for srfromgr Avatar for steviedee111 Avatar for teenlaqueefa Avatar for becca656 Avatar for ralph_vonholst Avatar for bonvivant Avatar for lastroth Avatar for midnight_rambler Avatar for darcy Avatar for addicted4444 Avatar for airportman Avatar for pabodie Avatar for tena Avatar for jinnj Avatar for chicago11 Avatar for joriep Avatar for onemorepoint Avatar for euglena4056 Avatar for occamscoin Avatar for yellowbeard Avatar for nydan516 Avatar for kovie Avatar for carpe_diem

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: